It’s always been about them getting something into clinic first in human (1 drug) and hopefully approved down the track. They seemed to narrow the focus down to just that 1 potential drug and now they’re tooting all these other candidates. Maybe trying to put a bit of safety net in so it doesn’t look like the carpets been pulled out if the lead doesn’t deliver as expected ?
PYC Price at posting:
5.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)